Copyright
©2014 Baishideng Publishing Group Inc.
World J Clin Urol. Nov 24, 2014; 3(3): 168-183
Published online Nov 24, 2014. doi: 10.5410/wjcu.v3.i3.168
Published online Nov 24, 2014. doi: 10.5410/wjcu.v3.i3.168
Component | Threshold |
Abdominal obesity | Sex- and population-specific waist circumference based on definitions established by IDF and AHA/NHLBI[8,9] |
Dyslipidemias (or pharmacologic treatment) | |
High triglycerides and/or | ≥ 150 mg/dL |
Low high-density lipoprotein cholesterol | < 40 mg/dL in males, < 50 mg/dL in females |
High blood pressure (or pharmacologic treatment) | Systolic ≥ 130 mm Hg and/or Diastolic ≥ 85 mm Hg |
High fasting glucose (or pharmacologic treatment) | ≥ 100 mg/dL |
- Citation: Strine AC, Rice KR, Masterson TA. Metabolic syndrome in the development and progression of prostate cancer. World J Clin Urol 2014; 3(3): 168-183
- URL: https://www.wjgnet.com/2219-2816/full/v3/i3/168.htm
- DOI: https://dx.doi.org/10.5410/wjcu.v3.i3.168